News & events
Last news about Indicia Biotechnology
December 2011 :Assessment of immunogenicity of biologics
December 1st 2011, by signing an agreement with Proteus, Indicia has acquired the rights to exploit Immuno'line™, a full range of services and patented technologies dedicated to Risk Assessment Immunogenicity.
September 2010 : Femtokine FUI project
The Femtokine project : grants by France’s Single Inter-Ministry Fund (FUI) – The objective is to develop novel biomarkers for the diagnosis and monitoring of Crohn’s Disease utilizing Singulex’s innovative Erenna® Immunoassay System.
May 2010 : Biomarker quantification at the femtogram level
Indicia Biotechnology and Singulex (USA) collaborates to provide ultrasensitive and early biomarker detection through Erenna® Immunoassay System (more information on our Biomarker Detection page).
September 2009 : Gliadys project
In collaboration with IDD Biotech, Indicia launches a new project, based on therapeutic antibodies against different glioma forms.
